Remogliflozin Etabonate, Vildagliptin, and Metformin are used in the treatment of type 2 diabetes mellitus.
How Remogliflozin Etabonate, Vildagliptin, and Metformin Work Remogliflozin Etabonate, Vildagliptin, and Metformin is a combination of three antidiabetic medications. Remogliflozin Etabonate lowers blood sugar levels by eliminating excess sugars through urine, thereby aiding in glycemic control for diabetic patients. Vildagliptin reduces the amount of glucose produced by the liver by raising insulin levels and decreasing glucagon levels, the hormone that increases blood glucose. Metformin limits the absorption of glucose from food and reduces glucose production by the liver. Additionally, Metformin enhances the body's response to insulin.
Common side effects of Remogliflozin Etabonate, Vildagliptin, and Metformin include hypoglycemia (low blood glucose level), nausea, vomiting, diarrhea, headache, dizziness, fatigue, trembling, and constipation.
Metformin 1000mg + Remogliflozin Etabonate 100mg + Vildagliptin 50mg

₹196.4

₹147.2
MRP ₹179.5
Metformin 500mg + Remogliflozin Etabonate 100mg + Vildagliptin 50mg

₹148
MRP ₹180.5
Metformin 1000mg + Remogliflozin Etabonate 100mg + Vildagliptin 50mg

₹176

₹147.2
MRP ₹179.5
Metformin 1000mg + Remogliflozin Etabonate 100mg + Vildagliptin 50mg

₹147.2
MRP ₹179.5
Metformin 500mg + Remogliflozin Etabonate 100mg + Vildagliptin 50mg

₹185.2

₹148
MRP ₹180.5